Regenesome¡¯s Proposed Theme Selected for the Acquisition, Technology & Logistics Agency¨CCommissioned ¡°Social Simulation Project¡±
Space Seed Holdings Co., Ltd. (Headquarters: Minato-ku, Tokyo; Representative Director: Kengo Suzuki) announces that its subsidiary, Regenesome Inc. (Headquarters: Minato-ku, Tokyo; President & CEO: Zentaro Sakuma; hereinafter ¡°Regenesome¡±), has been selected as one of the adopted companies for the ¡°Social Simulation Project*,¡± commissioned by the Defense Innovation Science & Technology Institute of the Acquisition, Technology & Logistics Agency (ATLA), Ministry of Defense.
* Social Simulation Project website:
This project supports research and development of new technologies capable of highly accurate prediction of rapidly changing social opinion distributions and psychological states. Regenesome¡¯s proposal, titled ¡°Predicting Social Opinion Distributions through the Integration of Well-being Indicators and Biometric Data,¡± has been adopted, and the company will now commence the development of a pioneering prototype.
Project Background and Significance
In modern society, the widespread use of social media and online media has accelerated the diversification of opinions and values, increasing uncertainty in policy-making and management decisions. To address this challenge, Regenesome aims to establish a new predictive technology that detects early ¡°signals of society¡± previously difficult to capture through conventional statistics, by integrating three key parameters: biometric data, psychological indicators, and social dynamics.
Future Outlook
Through this project, Regenesome will collaborate across multiple layers, including social sciences, medicine, and security, to develop new models that apply insights from aging, health, and mental well-being research. In addition, Regenesome plans to participate in the formation of a community among the selected project participants, expanding opportunities for knowledge sharing and collaborative solution creation.
About Regenesome Inc.
Regenesome aims to provide novel solutions for aging suppression and regenerative medicine by leveraging nanoparticles such as exosomes. Through detailed analysis of exosomes produced by various cells and the molecular biological design of nanoparticles, Regenesome seeks to elucidate how these particles function within the human body. By doing so, the company promotes the development of nanoparticle-based medical technologies and proposes new solutions in the field of space medicine, contributing to the extension of healthy life expectancy and the advancement of humanity into space.
About Space Seed Holdings Co., Ltd.
Space Seed Holdings is a space-oriented deep-tech venture builder engaged in investment, research, and business creation with the mission of ¡°turning science fiction into non-fiction.¡± Centered on initiatives such as the Fermentation and Longevity Fund, which supports the social implementation of fermentation and longevity technologies, the company works to create businesses that address global social challenges. By 2040, Space Seed Holdings aims to collaborate with diverse stakeholders to establish the technologies necessary for human habitation in outer space.
